Add office photos
Engaged Employer
Dr. Reddy's
4.1
based on 6.5k Reviews
Company Overview
Associated Companies
Company Locations
Working at Dr. Reddy's
Company Summary
We are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’
Overall Rating
4.1/5
based on 6.5k reviews
5% above
industry average
Highly rated for
Skill Development, Company Culture, Work-Life Balance
Critically rated for
Promotions/Appraisal
Work Policy
Work from office
77% employees reported
Monday to Friday
39% employees reported
Flexible timing
67% employees reported
No travel
37% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
559 employees reported
Health insurance
467 employees reported
Cafeteria
307 employees reported
Child care facility
297 employees reported
View all benefits
About Dr. Reddy's
Founded in1984 (41 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
Websitedrreddys.com
Primary Industry
Other Industries
We started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial presence across the globe, we serve over half a billion patients worldwide. We aspire to triple our reach and touch over 1.5 billion patients by 2030.
We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.
Our products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world. We work towards meeting unmet patients needs in the areas of gastro-enterology, cardiovascular, diabetology, oncology, pain management and dermatology. We are investing in businesses of the future including drug discovery, clinically-differentiated assets and digital healthcare.
Report error
AmbitionBox Best Places to Work in India Awards
Awards are based on 2021 reviews and ratings by employees of the company.
Congratulate
Know more
Share
Dr. Reddy's Ratings
based on 6.5k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
3.5k
4
1.8k
3
663
2
254
1
367
Category Ratings
4.0
Skill Development
3.9
Company Culture
3.9
Work-Life Balance
3.9
Salary & Benefits
3.7
Work Satisfaction
3.6
Job Security
3.4
Promotions/Appraisal
Dr. Reddy's is rated 4.1 out of 5 stars on AmbitionBox, based on 6.5k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Dr. Reddy's
based on 6.2k reviews
4.0
Rated by 712 Women
Rated 4.0 for Company Culture and 3.9 for Skill Development
4.1
Rated by 5.5k Men
Rated 4.0 for Skill Development and 3.9 for Company Culture
Work Policy at Dr. Reddy's
based on 591 reviews in last 6 months
Work from office
77%
Hybrid
20%
Permanent work from home
3%
Dr. Reddy's Reviews
Top mentions in Dr. Reddy's Reviews
+ 5 more
Compare Dr. Reddy's with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 6.5k reviews | 3.9/5 based on 1.8k reviews | 4.1/5 based on 5.6k reviews | 4.1/5 based on 6.6k reviews |
Highly Rated for | Skill development Company culture Work-Life balance | Job Security Work-Life balance | Salary & Benefits Job Security Skill development | Skill development Salary & Benefits Work-Life balance |
Critically Rated for | No critically rated category | Promotion/Appraisals | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 77% employees reported | Work from office 83% employees reported | Work from office 86% employees reported | Work from office 72% employees reported |
Rating by Women Employees | 4.0 Good rated by 712 women | 3.9 Good rated by 262 women | 4.1 Good rated by 407 women | 4.1 Good rated by 634 women |
Rating by Men Employees | 4.1 Good rated by 5.5k men | 3.9 Good rated by 1.5k men | 4.1 Good rated by 4.8k men | 4.1 Good rated by 5.6k men |
Job Security | 3.6 Good | 3.8 Good | 3.9 Good | 3.7 Good |
View more
Dr. Reddy's Salaries
3.9
rated by 6.5k employees for salariesTeam Member
(3.9k salaries)
Unlock
₹1.8 L/yr - ₹9.8 L/yr
Analytical Scientist
(786 salaries)
Unlock
₹3.6 L/yr - ₹12.5 L/yr
Senior Team Member
(520 salaries)
Unlock
₹3.8 L/yr - ₹13 L/yr
Area Sales Manager
(465 salaries)
Unlock
₹4.8 L/yr - ₹12.7 L/yr
Team Lead
(433 salaries)
Unlock
₹7 L/yr - ₹24 L/yr
Scientist
(288 salaries)
Unlock
₹4 L/yr - ₹14.6 L/yr
Production Specialist
(277 salaries)
Unlock
₹3.2 L/yr - ₹8 L/yr
Territory Manager
(261 salaries)
Unlock
₹2.6 L/yr - ₹7.2 L/yr
Formulation Scientist
(258 salaries)
Unlock
₹4 L/yr - ₹12.4 L/yr
Regional Sales Manager
(251 salaries)
Unlock
₹8 L/yr - ₹20 L/yr
Dr. Reddy's Interview Questions
Interview questions by designation
Top Dr. Reddy's interview questions and answers
Get interview-ready with top interview questions
Interview Process at Dr. Reddy's
based on 104 interviews in last 1 year
Interview Experience
4.3
Good
Difficulty level
Easy
20%
Moderate
69%
Hard
11%
People are getting interviews through
based on 261 Dr. Reddy's interviews
Job Portal
29%
Referral
21%
Walkin
15%
Company Website
8%
*27% candidates got the interview through other sources
High confidence
Dr. Reddy's Jobs
Dr. Reddy's News
View all
Stocks To Buy Today: Dr Reddy's, BHEL HCC, Aurobindo Pharma And More
- Analysts have shared 'buy' calls on BHEL, HCC, Dr Reddy's, Aurobindo Pharma, IPCA Labs, and Laurus Labs.
- Some of these companies could see upside of as much as 9% in the near term from current levels.
- Top stocks to buy, as recommended by experts: Dr Reddy's Laboratories, Aurobindo Pharma, Laurus Labs, HCC, IPCA Laboratories.
- Stocks like Dr Reddy's and Aurobindo Pharma have shown significant gains in the past 12 months.
Bloomberg Quint | 30 Dec, 2024
Markets end higher as pharma stocks lead gains; Sensex at 78,699
- The BSESensex closed at 78,699.07, up 226.59 points or 0.29 per cent, while the NSENifty 50 gained 63.20 points or 0.27 per cent to end at 23,813.40.
- Dr Reddy’s Laboratories emerged as the top gainer on the NSE, rising 2.72 per cent, followed by IndusInd Bank at 2.37 per cent, Mahindra & Mahindra at 2.23 per cent, Tata Motors at 1.78 per cent, and Eicher Motors at 1.51 per cent.
- Hindalco led the losses with a 1.73 per cent decline, followed by State Bank of India at 1.43 per cent, Coal India at 1.40 per cent, ONGC at 1.31 per cent, and Bharat Electronics Limited at 1.02 per cent.
- The broader market indices underperformed the benchmarks, with the Nifty Next 50 declining 0.88 per cent to 68,557.15 and the Nifty Midcap Select falling 0.18 per cent to 12,768.90.
HinduBusinessLine | 27 Dec, 2024
Trading Ideas: Don't Buy Axis Bank, NCC At Current Levels, Say Stock Market Experts
- Stock market experts advise against buying Axis Bank and NCC at current levels.
- Kushal Gandhi suggests avoiding Axis Bank as it has been on a downtrend with selling pressure sustaining.
- Sameer Dalal recommends buying NCC at lower levels, expecting a decent return over the next two years.
- Dalal advises investors to switch from Abbott India to Dr Reddy's Laboratories due to the latter's larger growth opportunity.
Bloomberg Quint | 20 Dec, 2024
Markets extend losses as Banks, IT lead decline; Dr Reddy’s bucks trend
- Market breadth remained negative with 2,187 stocks declining versus 1,659 advances on the BSE.
- Banking stocks continued to slide, with Axis Bank and IndusInd Bank among the top losers.
- Dr Reddy’s Laboratories led the gainers on the Nifty, followed by Hindalco Industries.
- Tech Mahindra, Larsen & Toubro, and UltraTech Cement were among the significant losers.
HinduBusinessLine | 20 Dec, 2024
Sensex plunges 964 points as Fed’s hawkish stance sparks market sell-off
- Sensex plunges 964 points as Fed’s hawkish stance sparks market sell-off
- Dr Reddy’s, Cipla, BPCL, Sun Pharma, and Apollo Hospitals emerge as gainers
- Banking and financial services sectors witness significant decline
- Market volatility increases with circuit filters triggered for multiple stocks
HinduBusinessLine | 19 Dec, 2024
Sensex, Nifty slump in early trade as US Fed indicates fewer rate cuts next year
- Sensex and Nifty open sharply lower, down by 0.87% and 0.91% respectively.
- Dr Reddy’s Laboratories and Tata Consumer Products show gains, while Wipro, Shriram Finance, Asian Paints, Hindalco, and ONGC witness declines.
- US Fed cuts interest rates and indicates only two rate cuts in 2025, triggering a global sell-off.
- Market weakness amplified by the rise in dollar index, spike in US 10-year bond yield, and foreign fund outflows.
HinduBusinessLine | 19 Dec, 2024
Market volatility continues: Sensex and Nifty slide amid midday trading
- The Sensex and Nifty have declined during midday trading, with Sensex dropping by 0.60% and Nifty by 0.56%.
- Broader market indices such as Nifty Next 50 and Nifty Midcap Select are also down by 1.09% and 0.28% respectively.
- The market breadth indicates widespread selling pressure with a higher number of declining stocks compared to advancing stocks.
- Sector-wise, Dr Reddy’s Laboratories is leading the gainers, while Bharat Electronics (BEL) is the top loser.
HinduBusinessLine | 18 Dec, 2024
Market slides ahead of Federal Reserve’s pivotal interest rate decision
- Markets are focused on the Federal Open Market Committee's interest rate decision.
- Nifty 50 saw Dr Reddy’s as the top gainer while Tata Motors was the biggest loser.
- Foreign institutional investors sold equities worth ₹6,500 crore on Tuesday.
- Sectoral performance showed mixed trends, with hotel and real estate stocks expected to perform well.
HinduBusinessLine | 18 Dec, 2024
Nifty Pharma, Healthcare Snap Two-Day Fall Post Jefferies' Outlook
- Nifty Pharma and Nifty Healthcare snapped their two-day fall and rose on Tuesday, following a report by Jefferies on its takeaways from its tour of pharma companies across Delhi, Mumbai, and Hyderabad.
- The report mentioned that non-price metrics are being given due importance for supplier selection and hospitals are looking to add new geographies once the home turf is well protected.
- Indian generic firms with meaningful exposure to the US market are adopting different strategies to avoid price erosion, such as moving up the value chain and pursuing complex products.
- In Nifty Healthcare, Glenmark Pharma, Syngene International, and Apollo Hospitals were among the top gainers, while Dr Reddy's Labs, Zydus Lifesciences, and Aurobindo Pharma fell the most.
Bloomberg Quint | 10 Dec, 2024
Market dips slightly as RBI holds steady, signals economic caution
- The Sensex retreated 56.74 points or 0.07% to close at 81,709.12, while the Nifty 50 slipped 30.60 points or 0.12% to 24,677.80.
- Top gainers for the day included Tata Motors, Bajaj Auto, Axis Bank, BPCL, and Dr Reddy’s Lab.
- The RBI's MPC meeting highlighted optimism in growth revival and the strategic liquidity measures taken to stimulate economic growth.
- The market showed resilience in midcap and smallcap segments, and investors adopted a 'buy on dips' strategy.
HinduBusinessLine | 6 Dec, 2024
Powered by
Dr. Reddy's Subsidiaries
Aurigene Oncology Limited
4.3
• 228 reviews
Aurigene Pharmaceutical Services
4.1
• 196 reviews
SVAAS Wellness
4.0
• 11 reviews
Report error
Dr. Reddy's Offices
Compare Dr. Reddy's with
Lupin
4.2
Zydus Lifesciences
4.1
Glenmark Pharmaceuticals
4.0
Torrent Pharmaceuticals
3.9
Aurobindo Pharma
4.0
DIVI'S Laboratories
3.8
Alembic Pharmaceuticals
4.0
Viatris
4.2
Abbott
4.2
Alkem Laboratories
3.9
Ipca Laboratories
4.0
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
Wockhardt
3.9
Piramal Group
3.9
Sanofi
4.3
Indoco Remedies
3.6
Contribute & help others!
You can choose to be anonymous
Companies Similar to Dr. Reddy's
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.1
• 5.6k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.6k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.8k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.8k reviews
Glenmark Pharmaceuticals
Pharma
4.0
• 2.7k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.4k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.6k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.3k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 2.9k reviews
Dr. Reddy's FAQs
When was Dr. Reddy's founded?
Where is the Dr. Reddy's headquarters located?
How many employees does Dr. Reddy's have in India?
Does Dr. Reddy's have good work-life balance?
Is Dr. Reddy's good for career growth?
What are the pros of working in Dr. Reddy's?
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
